Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-α-induced proliferation of B chronic lymphocytic leukemia cells

Abstract

The proliferative response of purified malignant B cells from 26 patients with chronic lymphocytic leukemia (CLL) was investigated in vitro. In the majority of these patients, a proliferative response could be induced by the combination of tumor necrosis factor (TNF)-α and PMA. The concentration of PMA was found to be critical and showed a sharp optimum. In most cases maximal proliferation was obtained with as little as 0.1 ng/mL PMA. In all cases tested, TNF-α-induced proliferation could be inhibited completely by the addition of low doses of interleukin-4 (IL-4). Maximal inhibition was already found with 400 pg/mL IL-4. Inhibition by IL-4 was not caused by a downmodulation of TNF receptors. Apart from TNF-α, IL-2 was also in synergy with PMA able to induce proliferation in B-CLL cells of some patients. This IL-2-induced proliferation could be inhibited both by IL-4 and by neutralizing anti-TNF-α antibodies. This shows that TNF-α also can act as an autocrine growth factor. These data indicate that TNF-α is an important growth factor for neoplastic B-CLL cells and that IL-4 provides a tool to interfere with this TNF-α response. © 1992 by The American Society of Hematology.